NanoVation Therapeutics™

📸 October Highlights at NanoVation Therapeutics (NTx)    October brought a series of impactful events for the NTx team! Here’s a look back at some memorable moments:   🇨🇦 Representing NTx at RNA Canada ARN Our co-founder and Board Chair, Pieter Cullis, presented the transformative potential of personalized RNA therapeutics powered by lipid nanoparticles, sparking insightful discussions within the field.   🤝 Networking at EFCG Meaningful connections and exciting conversations at the EFCG - European Fine Chemicals Group event during CPHI Milan! It was fantastic to connect with industry experts on the future of lipid and LNP manufacturing.   💪 Giving Back at Ronald McDonald House Our team volunteered at Ronald McDonald House BC and Yukon, cooking a warm, nutritious meal for families staying near BC Children’s Hospital. It was an honor to support all families and their kids fighting severe diseases. Find out how you can support RMH: https://rmhbc.ca/   🎤 CEO Insights at the ESMI Webinar Our CEO, Dominik Witzigmann, PhD, shared insights on the role of lipid nanoparticles in genetic medicine. Watch the full session here: https://lnkd.in/dp_RXheg Special thanks to Alexandros Marios Sofias, PhD and Doris Kracht for the invitation and seamless organization.   🎉 Halloween Afterwork Fun We celebrated Halloween in style with a Werewolf-themed afterwork party! Our team got into the spooky spirit with games, costumes, and plenty of laughs to end October on a high note.   Thank you to everyone who made these moments memorable! Looking forward to more impactful collaborations and events.    #NanoVationTherapeutics #Innovation #Biotech #Community #GeneticMedicine #NanoVators #LNP #NucleicAcid #RNA

🌟 Focus on NanoVator: Eleonore Rayner 🌟   Meet Eleonore Rayner, "Elle," who plays a key role as a Project Manager at NanoVation Therapeutics. Since day one, Elle has been instrumental in driving forward internal R&D projects as well as collaborations with strategic partners.    🔧 Currently, Elle's focus is on improving, automating, and pressure-testing existing processes to meet the needs of our growing team. Her dedication and leadership are helping us be the catalytic partner enabling genetic medicines to prevent, treat, or cure diseases. 💡   🎉 Fun fact about Elle? She holds a Guinness World Record for 'the most number of pancakes flipped in one minute' (along with probably 889 other students). 🥞🥇 https://lnkd.in/d6P_CBPU   We are proud to have Elle as part of the NanoVation team!    #NanoVationTherapeutics #ProjectManager #Innovation #Biotech

Curious about the latest advancements in mRNA and lipid nanoparticle technologies? 🔬✨   NanoVation Therapeutics is excited to be attending the mRNA Health Conference in Boston from November 12-14. 📅   NTx Attendees: Jayesh Kulkarni, Daniel Kurek, Lívia Palmerston Mendes, Nicola Pett   NTx Speaker: Our co-founder Christian Kastrup, will present "Genetically engineered transfusable platelets using mRNA lipid nanoparticles." 🎤   Join us to connect with our team and learn more about our cutting-edge work in lipid nanoparticles (LNPs) and nucleic acid delivery.   For more information, visit nanovationtx.com.   #mRNA #GeneticMedicine #LNPs #Innovation #mRNAHealthConference #NanoVationTherapeutics #NucleicAcid

🌟 Focus on New NanoVator 🌟   We’re excited to welcome Mayara Brandao to the NanoVation Therapeutics team as our new Senior Manager, People & Culture!   Mayara will play a key role in extending our People & Culture department, driving our  P&C strategy and leading  P&C initiatives. Her leadership will be instrumental in supporting our team and aligning with our corporate objectives as we continue to grow and innovate.   Welcome, Mayara! We’re thrilled to have you on board as we work together to shape the future of NanoVation.   #NanoVationTherapeutics #PeopleAndCulture #HRLeadership #Innovation #LNP #RNA #NucleicAcid

🌍 NanoVation Therapeutics  is proud to participate in the prestigious The Royal Society in London on November 7-8! Representing us is our CSO, Jayesh Kulkarni, who will be delivering insights on how Lipid nanoparticles are transforming the delivery of nucleic acids to enable groundbreaking gene therapies beyond the liver.   We’re excited to join leading experts and visionaries to explore how these advancements can transform patient outcomes.   A special thank you to Diyura Sasitharan and Kaeli Johnson for the invitation and the opportunity to contribute to this groundbreaking event.   Let’s keep driving innovation forward! 💡   #Biotech #CellTherapy #GeneDelivery #Innovation #RoyalSocietyMeeting  #NanoVationTherapeutics #GeneticMedicines #NucleicAcids #LNP 

🌍 Join Us at BIO Europe Fall 2024 in Stockholm! 🌍   We’re excited to announce that our CSO, Jayesh Kulkarni, and BD Associate, Kate Hollinshead, Ph.D., will be attending the highly anticipated #BIO Europe Fall from November 4-6 in Stockholm!   This is a fantastic opportunity to connect, network, and explore how NanoVation Therapeutics can support your initiatives with our comprehensive one-stop-shop IP portfolio. Learn more about our innovative technologies and how we’re advancing genetic medicine: https://lnkd.in/eSrAiND8   #NanoVationTherapeutics #BIOEuropeFall #LNP #RNA #NucleicAcids #Biotechnology #Innovation #GeneticMedicines

🌿 Healthy Workplace Month at NanoVation Therapeutics 🌿   At NTx, we know that a healthy workplace fuels both personal and professional growth. This October, in celebration of Healthy Workplace Month, we’re reflecting on the importance of prioritizing both physical and mental well-being.   One of our proud initiatives this year was Bike to Work Week in June, where our team embraced physical activity and sustainability by swapping cars for bikes and recharging their energy outdoors! 🚴♀️   In addition, we make a point of organizing monthly outdoor activities like our cherry blossom walk, allowing our nanovators to connect with nature, stay active, and foster stronger team connections.   🧠 Mental Health Resources: We also prioritize mental well-being by encouraging access to support networks, counseling services, and mental health days—because taking care of our minds is just as important as taking care of our bodies.   🌱 Creating a Supportive Culture: We strive to create a culture where employees feel heard, valued, and empowered. Open communication and mutual respect are key to ensuring that everyone thrives.   Together, we can continue building a work environment that empowers our team to be their best selves—physically, mentally, and professionally!   #HealthyWorkplaceMonth #WellBeingAtWork #MentalHealthMatters #NanoVationTherapeutics #Nanovators 

🔊 We’re Hiring: Vice President, Business Development!    NTx is looking for a dynamic Vice President, Business Development. As a key member of the senior leadership team, you will drive business development and marketing strategies, secure strategic partnerships, and help shape the future of genetic medicine.   📩 Apply now: https://lnkd.in/dcDuCvhw #BiotechCareers #BusinessDevelopment #HiringNow #Innovation

🔬 NTx Focus on Science: Congratulations to Our Senior Associate Scientist, Ariane! 🔬   We are proud to announce the publication of Ariane Miriam Nissenbaum and her colleagues on "Comprehensive Impurity Profiling of mRNA: Evaluating Current Technologies and Advanced Analytical Techniques". This important work contributes to the ongoing development of mRNA technologies and provides valuable insights into impurity profiling.   📖 Read the full publication here: https://lnkd.in/edeJdgty   If you have questions about Ariane's focus at NTx, she will be participating in the RNA and AI Symposium at the Sanford Consortium on October 29.    Congratulations, Ariane, for your significant contributions to the field of RNA research!   #NanoVationTherapeutics #RNA #Publication #Research #Innovation #LNP #NucleicAcids #Science

🌟 Spotlight on Our Scientist: Grishma! 🌟   We are excited to announce that Grishma Pawar, Ph.D, our Scientist II in Preclinical Research, will be presenting at the upcoming European Society of Gene and Cell Therapy conference!   Grishma focuses on designing and executing preclinical in vivo studies to investigate our novel NTx lipid nanoparticle (#LNP) technologies for RNA-based vaccine applications.   🔍 Poster Presentation Details: Title: Development of Novel and Robust LNP-RNA Vaccines Poster Number: P044 Session: Poster Session I Date: Tuesday, 22 October Time: 19:30 - 21:00   Take the opportunity and chat with Grishma as she shares NTx groundbreaking research on the next generation of LNP-RNA vaccines!    #NanoVationTherapeutics #ESGCT #PreclinicalResearch #LipidNanoparticles #mRNA #Innovation